Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Operating expenses
Research and development costs	$ 879,843	$ 50,957	$ 1,076,487	$ 70,957
General and administrative expenses	2,309,149	716,551	8,740,862	1,533,253
Amortization of intangible assets	174,019		310,659
Total operating expenses	3,363,011	767,508	10,128,008	1,604,210
Loss from Operations	(3,363,011)	(767,508)	(10,128,008)	(1,604,210)
Other income (expense)
Interest expense	(4,821)	(50,883)	(4,821)	(312,642)
Change in fair value of warrant liabilities	2,459,543		6,272,543
Inducement expense			(298,714)
Total other income (expense)	2,454,722	(50,883)	5,969,008	(312,642)
Net Loss	(908,289)	(818,391)	(4,159,000)	(1,916,852)
Other comprehensive gain (loss)
Foreign currency translation	(33,262)	(10,069)	2,474	(22,767)
Comprehensive loss	$ (941,551)	$ (828,460)	$ (4,156,526)	$ (1,939,619)
Net loss per share – basic and diluted	$ (0.04)	$ (0.15)	$ (0.22)	$ (0.34)
Weighted average shares outstanding, basic and diluted	21,333,515	5,672,025	18,692,526	5,668,471